Back to search

Article

TTI-0102: A Novel Natural Controlled-Release Cysteamine Prodrug for Mitochondrial Disease and Cystinosis

2026-03-31

Abstract excerpt

<h4>Background</h4> Cysteamine is the only disease-modifying therapy for nephropathic cystinosis and has shown promise in mitochondrial disorders, but its clinical utility is limited by poor tolerability due to high peak concentrations with existing formulations. TTI-0102 is a novel natural controlled-release cysteamine prodrug designed to provide sustained cysteamine exposure with improved tolerability. <h4>Meth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98119deb-c76b-5a87-a1f4-155242e886b4
DOI
10.64898/2026.03.26.26347968
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TTI-0102: A Novel Natural Controlled-Release Cysteamine Prodrug for Mitochondrial Disease and CystinosisDOI 10.64898/2026.03.26.26347968
Cysteamine-bicalutamide combination treatment restores alpha-ketoglutarate and corrects proximal tubule phenotype in cystinosisSemantic proximity
Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis.Semantic proximity
Unmet patient needs in monocarboxylate transporter 8 (MCT8) deficiency: a reviewSemantic proximity
Effects of long-term cysteamine treatment in patients with cystinosis.Semantic proximity
Cysteamine revisited: repair of arginine to cysteine mutations.Semantic proximity
Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.Semantic proximity
Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-BedsideSemantic proximity
Substrate transport and drug interaction of human thiamine transporters SLC19A2/A3Semantic proximity
The monocarboxylate transporter family--role and regulation.Semantic proximity
Cystinosis.Semantic proximity
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug DesignSemantic proximity
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug DesignSemantic proximity
Select a neighboring publication to make it the new centre.